Treating Alzheimer's? Don't forget about cholinesterase inhibitor drug interactions

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 20, Iss. 7, 2004-07 ,pp. : 20-22

Adis International

Access to resources Recommend Favorite

The Role of Glucose in the Pathogenesis of Alzheimer's Disease Revisited:What Does it Tell us About the Therapeutic use of Lithium?

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 6, Iss. 3, 2006-01 ,pp. : 175-192

Bentham Science Publishers

Access to resources Recommend Favorite

CAN THE CONTROVERSY OF THE ROLE OF ALUMINUM IN ALZHEIMER'S DISEASE BE RESOLVED? WHAT ARE THE SUGGESTED APPROACHES TO THIS CONTROVERSY AND METHODOLOGICAL ISSUES TO BE CONSIDERED?

By Savory John   Exley Christopher   Forbes William F.   Huang Yue   Joshi Jayant G.   Kruck Theo   Mclachlan Donald R. C.   Wakayama Ikuro  

Journal of Toxicology and Environmental Health, Vol. 48, Iss. 6, 1996-08 ,pp. : 615-636

Taylor & Francis Ltd

Access to resources Recommend Favorite

The Epidemic of Alzheimer's Disease: How Can We Manage the Costs?

By Johnson N.  

PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. : 215-223

Adis International

Access to resources Recommend Favorite

The Economic Impact of Neuropsychiatric Symptoms in Alzheimer’s Disease: Can Drugs Ease the Burden?

By Murman Daniel L.  

PharmacoEconomics, Vol. 23, Iss. 3, 2005-01 ,pp. : 227-242

Adis International

Access to resources Recommend Favorite